EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Need for Next-Generation Antivenom for Snakebite Envenomation in India

Muralidharan Vanuopadath iD, Karthika Rajan, Aswathy Alangode, Sudarslal Sadasivan Nair, Bipin Gopalakrishnan Nair

Toxins · 18.08.2023 · 15 (8) · 510

DOI: 10.3390/toxins15080510 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 18.08.2023. Verfasst von Muralidharan Vanuopadath und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690 525, Kerala, India. Hauptthemen laut MEDLINE: Snake Bites, Biological Products. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health Research, Indian Council of Medical Research, Government of India, Amrita Vishwa Vidyapeetham.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limitations posed by currently available antivenoms have emphasized the need for alternative treatments to counteract snakebite envenomation. Even though exact epidemiological data are lacking, reports have indicated that most global snakebite deaths are reported in India. Among the many problems associated with snakebite envenomation, issues related to the availability of safer and more efficient antivenoms are of primary concern. Since India has the highest number of global snakebite deaths, efforts should be made to reduce the burden associated with snakebite envenoming. Alternative methods, including aptamers, camel antivenoms, phage display techniques for generating high-affinity antibodies and antibody fragments, small-molecule inhibitors, and natural products, are currently being investigated for their effectiveness. These alternative methods have shown promise in vitro, but their in vivo effectiveness should also be evaluated. In this review, the issues associated with Indian polyvalent antivenoms in neutralizing venom components from geographically distant species are discussed in detail. In a nutshell, this review gives an overview of the current drawbacks of using animal-derived antivenoms and several alternative strategies that are currently being widely explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Snake BitesBiological ProductsAnimalsHumansAntiveninsAsian PeopleCamelusIndia

Stichwörter der Autor:innen

Indian polyvalent antivenomantivenomicsaptamersimmunological cross-reactivitynatural productsnext-generation antivenomphage displaysmall-molecule inhibitorssnake venomics

Substanzen

AntiveninsBiological Products

Autor:innen und Institutionen

  • School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam 690 525, Kerala, India.

ORCID-Profile: Muralidharan Vanuopadath

Förderung

  • Department of Health Research, Indian Council of Medical Research, Government of India
  • Amrita Vishwa Vidyapeetham

Zitieren

APA

Vanuopadath, M., Rajan, K., Alangode, A., Nair, S. S., & Nair, B. G. (2023). The Need for Next-Generation Antivenom for Snakebite Envenomation in India. Toxins, 15(8), 510. https://doi.org/10.3390/toxins15080510

Vancouver

Vanuopadath M, Rajan K, Alangode A, Nair SS, Nair BG. The Need for Next-Generation Antivenom for Snakebite Envenomation in India. Toxins. 2023;15(8):510. doi:10.3390/toxins15080510

BibTeX
@article{Vanuopadath2023,
  author = {Vanuopadath, Muralidharan and Rajan, Karthika and Alangode, Aswathy and Nair, Sudarslal Sadasivan and Nair, Bipin Gopalakrishnan},
  title = {The Need for Next-Generation Antivenom for Snakebite Envenomation in India},
  journal = {Toxins},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {510},
  doi = {10.3390/toxins15080510}
}
Kostenlos starten →